Brainshake aims to bring extensive biological data to routine healthcare, aiming to replace reactive healthcare and enable preventive medicine in chronic diseases.
As a part of the investment, TJP Consulting, a Finnish growth company accelerator, joins Brainshake as a strategic partner.
“The disruptive power of Brainshake’s technology relies in extensive scientific background and scalability allowing the blood analysis to be used in routine health care,” Tuomas Poskiparta, Chairman of TJP Consulting said in a statement.
The lead investor of Brainshake’s Round A, Finnish growth venture Cor Group, also participated in the investment round, strengthening their role as a shareholder and long-term strategic partner. Brainshake is also a member of one of the world’s biggest health-focused start-up accelerators StartUp Health.
The company’s revenue in 2015 was 1.6 million euros, of which over 95% came from export.